The Daegu-Gyeongbuk Free Economic Zone Authority (Commissioner Kim Byung-sam) held an 'Investment Attraction Briefing for Bio·Medical Companies in the Kansai (關西) Region' on the 5th in Osaka, Japan, to attract Japanese companies.


This briefing was hosted by the Daegu-Gyeongbuk Free Economic Zone Authority and organized by the Korea Trade-Investment Promotion Agency (KOTRA) Osaka Trade Center, with about 300 participants including members of the Kansai Pharmaceutical Association and pharmaceutical and medical device companies from the Kansai region.

Daegu-Gyeongbuk Economic Zone Authority is holding an investment attraction briefing session targeting biomedical companies in the Kansai region in Osaka, Japan.

Daegu-Gyeongbuk Economic Zone Authority is holding an investment attraction briefing session targeting biomedical companies in the Kansai region in Osaka, Japan.

View original image

On this day, the Daegu-Gyeongbuk Free Economic Zone Authority introduced the investment environment related to the bio·medical industry in the Daegu-Gyeongbuk Free Economic Zone, such as the 'Pohang Convergence Technology Industrial District' and the 'Shinseo Advanced Medical District,' actively explaining the region's investment strengths and benefits for resident companies.


In addition, KOTRA Osaka Trade Center explained Korea's plans to foster and support the pharmaceutical and bio industries, and promising domestic medical companies participated to provide an overview of recent trends in Korean pharmaceutical administration.


This investment attraction briefing was held for the first time in two years, and the Kansai region of Japan, centered on Osaka, Kyoto, and Kobe, is a key hub of Japan's bio·medical industry, densely populated with research institutes, universities, and major pharmaceutical companies.


The Daegu-Gyeongbuk Free Economic Zone Authority held a strategic investment attraction briefing focusing on districts specialized in the bio·medical field within the Free Economic Zone.


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

Kim Byung-sam, Commissioner of the Daegu-Gyeongbuk Free Economic Zone Authority, stated, “We will actively promote the attractiveness of Daegu-Gyeongbuk as a promising region for investment in the global advanced medical industry, discover promising investment companies, and strive to achieve tangible investment attraction results.” He also expressed the intention for Korean and Japanese companies to achieve mutual win-win outcomes in the global market through this briefing.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing